Proxy Votes Now

Home › Funds › Jackson National › JNL Emerging Markets Index Fund

JNL Emerging Markets Index Fund proxy voting record 2024-2025

Fund family: Jackson National · Filed by JNL SERIES TRUST (CIK 933691) · SEC series S000071123

2023-20242024-20252025-2026

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 25,026 with, 41 against, 1,137 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 10 FOR, 32 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Jackson National as a whole

The same two figures as Jackson National’s manager page (255,939 ballot items across 95 funds and accounts), counted the same way for this fund.

2024-2025This fundItemsJackson NationalItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)83.3%18,22591.9%216,881
Backed environmental and social shareholder proposals at US companiesn/a03.6%3,792

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Capital Structure6,2581
Director Elections5,77735
Other4,6074
Corporate Governance3,0991
Extraordinary Transactions2,5040
Audit-related1,8600
Compensation1,8140
Shareholder Rights and Defenses1760
Other Social Issues530
Say-on-Pay500

Notable votes against management

MeetingCompanyProposalFundMgmt
January 23, 2025KOREA ZINC CO LTDAPPOINTMENT OF (NON-EXECUTIVE) DIRECTOR SUNG-DOO KANG (SHAREHOLDER PROPOSAL_YOUNG POONG CO., LTD.) Shareholder proposalAgainstFor
January 23, 2025KOREA ZINC CO LTDAPPOINTMENT OF (NON-EXECUTIVE) DIRECTOR KWANG-IL KIM (SHAREHOLDER PROPOSAL_YOUNG POONG CO., LTD.) Shareholder proposalForAgainst
March 31, 2025COWAY CO., LTD.PLEASE NOTE THAT THIS RESOLUTION IS A SHAREHOLDER PROPOSAL: INTRODUCTION OF CUMULATIVE VOTING Shareholder proposalAgainstFor
December 19, 2024HANMI PHARM CO LTDPLEASE NOTE THAT THIS RESOLUTION IS A SHAREHOLDER PROPOSAL: DISMISSAL OF INSIDE DIRECTOR PARK JAE-HYUN Shareholder proposalAgainstFor
December 19, 2024HANMI PHARM CO LTDPLEASE NOTE THAT THIS RESOLUTION IS A SHAREHOLDER PROPOSAL: DISMISSAL OF NON-EXECUTIVE NON-INDEPENDENT DIRECTOR SHIN DONG-KUK Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (1 in 2024-2025), and how the fund voted the items on its ballot.

Every vote, 2024-2025

The vote-by-vote list is kept for the latest season, 2025-2026. Every vote of 2024-2025 is in the interactive database, company by company, under Jackson National.

About this fund’s record

In the 2024-2025 proxy season, JNL Emerging Markets Index Fund voted at 2,978 shareholder meetings of 1,422 companies, on 26,205 ballot items in all. Where management made a recommendation, the fund followed it on 95.5% of the items and voted against it 41 times. Its most frequent area of disagreement was director elections (35 of its votes against management). It voted on 42 shareholder proposals. It voted FOR the board's own proposals less often than Jackson National's funds as a whole (83.3% against 91.9%). 1 of its meetings was contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Jackson National’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.